Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × Vinorelbine × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 9 Neoplasm Metastasis 6 Hodgkin Disease 6 Neoplasms 4 Recurrence 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2 Mesothelioma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Carcinoma 2 Breast Neoplasms, Male 2 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Pleural Effusion, Malignant 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non - Small Cell Lung Cancer NSCLC 1 Neuroendocrine Tumors 1 Neuralgia 1 Metatropic dwarfism 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Locally Advanced Non-Small Cell Lung Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Desmoplastic Small Round Cell Tumor 1

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡